International Network of VENous Thromboembolism Clinical Research Networks

About INVENT

INVENT is an independent, not-for-profit network of academic research groups. INVENT exists to promote international collaboration between academic research networks that conduct venous thromboembolism (VTE) related clinical research, and to enhance the profile, science, and impact of investigator-led VTE clinical research. INVENT seeks to enable research by its member groups, rather than to supplant the activities of individual member groups, and to promote a global culture of curiosity, scientific rigor and social responsibility in the conduct of VTE clinical research.

​Participating INVENT network members include CanVECTOR (Canada), INNOVTE (France), INViTE (Ireland), DTN (Netherlands), Center for Thrombosis and Hemostasis (Germany), TRIP (Italy), Norwegian Thrombosis Network, THANZ (Australia and New Zealand), and VENUS (USA).

 

Vision

The vision of INVENT is to:

  • Be the recognized international driver and accelerator for patient-oriented, investigator-initiated VTE clinical research
  • Be endorsed and supported by the leading scientific societies and top granting agencies worldwide
  • Be the key facilitator for international collaboration among VTE clinical investigators, including networking for young investigators
  • Be the international leader in promoting the development of national VTE networks
  • Identify key unanswered VTE clinical research questions and design/conduct the studies to answer them

Subscribe

* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.